Humanized anti-CD20 antibody, veltuzumab, in refractory/recurrent non-Hodgkin's lymphoma: phase I/II results.

Details

Language :

English

ISSN :

0732183X

Volume :

27

Issue :

20

Database :

Supplemental Index

Journal :

Journal of Clinical Oncology

Publication Type :

Academic Journal

Accession number :

105376291

Full Text :

https://doi.org/10.1200/JCO.2008.19.9117